Primary Endpoint: Cardiovascular Mortality/Hospitalization for Worsening HF.
Reproduced from The Lancet, Volume 376, Issue 9744, Swedberg K, Komajda M, Bohm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Copyright 2010, with permission from Elsevier.
Reproduced from The Lancet, Volume 376, Issue 9744, Swedberg K, Komajda M, Bohm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Copyright 2010, with permission from Elsevier.